The latest news from Arcinova
April 27, 2019
Industry Insights with… Paul Quigley
To coincide with CPhI North America 2019, we asked our Head of Drug Substance, Paul Quigley, to share his thoughts on the changing CDMO sector. The latest blog in our Industry Insights series high
April 26, 2019
Accelerating the path to first-in-human clinical trials
Our Head of Drug Substance, Paul Quigley, was recently interviewed by Outsourcing Pharma to coincide with his presentation at CPhI North America 2019. He explained the importance of ensuring rapid
April 17, 2019
Article: Chemistry 4.0 in pharmaceutical development
"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the
April 16, 2019
Crédit d'impôt recherche Grants Arcinova with R&D Status
Arcinova has been recognised and approved by the Crédit d'impôt recherche (CIR) as an organisation undertaking R&D activities. This will bestow significant benefits upon any French cus
April 8, 2019
Industry Insights with… Samuel Bourne
Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their extensive expertise on topics within the pharmaceutical industry. We recently asked our Process
March 18, 2019
Investigating multi-dimensional problems in drug substance
"Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise." Our CSO, Gareth
March 12, 2019
Industry Insights with… Stephen Byard
Welcome to our Industry Insights series, where we provide a platform for our scientists to share their extensive knowledge of subjects within pharmaceutical development. In the first blog of this
February 18, 2019
Panel discussion on Pharma and Chemical Supply Chain
Our CSO, Gareth Jenkins, took part in a panel discussion on the pharmaceutical supply chain. He offered his insights on the key issues and trends shaping the industry and the fac
February 5, 2019
Arcinova's Chief Scientific Consultant Wins 2019 Scholar Award
Dr. Aggarwal is currently working as a Chemistry Professor at the University of Bristol however, Dr. Aggarwal also works with Arcinova in January 2018 as our Chief Scientific ConsulDiscover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
